.png){kind=icon}
返回
Multidisciplinary considerations for implementing Bayesian borrowing in basket trials
.png){kind=icon}
PRE
AI
DOI：10.1016/j.drudis.2024.104127.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Drug development has historically relied on phase I-III clinical trials including participants sharing the same disease. However, drug development has evolved as the discovery of mechanistic drivers of disease demonstrated that the same therapeutic target may provide benefits across different diseases. A basket trial condenses evaluation of one therapy among multiple related diseases into a single trial and presents an opportunity to borrow information across them rather than viewing each in isolation. Borrowing is a statistical tool but requires a foundation of clinical and therapeutic mechanistic justification. We review the Bayesian borrowing approach, including its assumptions, and provide a framework for how this approach can be evaluated for successful use in a basket trial for drug development.
Keyword:
Bayesian
borrowing
basket
master protocol
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
Virus-induced diabetes in mice: A quantitative evaluation of islet cell population by immunofluorescence technique.png)
Diabetologia
OAAI
DiabetologiaIF0
OAAI分享收藏
查看更多内容